Third Harmonic Bio

IPO

Third Harmonic Bio is a life sciences company in Boston, United States, founded in 2019. It has raised $155.0M across 3 rounds, most recently a $105.0M Series B in December 2021.

Headquarters
Boston
Employees
11–50
Founded
2019
Total Funding
$155.0M
Last Round
$105.0M Series BDec 2021
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.

About

Third Harmonic Bio is a clinical-stage biopharmaceutical company based in Boston, Massachusetts, founded in 2019 by Atlas Venture. It is developing a first-in-class, highly selective oral KIT inhibitor licensed from Novartis for chronic urticaria, asthma, and other mast cell-driven allergic and inflammatory diseases. The company emerged from stealth in February 2022 with a $155 million Series B financing backed by General Atlantic and Atlas Venture. In April 2025 it announced a wind-down of operations after discontinuing its lead clinical program.

Summary

It lists 11–50 employees. It has raised $155.0M in total across 3 rounds, most recently a $105.0M Series B round in Dec 2021. Investors include Atlas Venture, OrbiMed and BVF Partners.

Funding & Exit History

Data from Indexed.vcUpdated
IPOSep 2022
$185.3M

Sign up to see all 4 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare, Life Sciences
Private EquityTotal funding$1.9BMar 2021

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Third Harmonic Bio on Indexed.vc
<a href="https://indexed.vc/companies/third-harmonic-bio"><img src="https://indexed.vc/api/badge/company/third-harmonic-bio" alt="Third Harmonic Bio on Indexed.vc" width="260" height="76" /></a>